Sumitomo Life Insurance’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$777K Buy
8,972
+196
+2% +$18.8K 0.02% 217
2025
Q4
$843K Buy
8,776
+88
+1% +$8.55K 0.02% 205
2025
Q3
$827K Sell
8,688
-304
-3% -$27.9K 0.03% 199
2025
Q2
$784K Sell
8,992
-9,220
-51% -$782K 0.05% 196
2025
Q1
$1.64M Sell
18,212
-7
-0% -$626 0.06% 136
2024
Q4
$1.46M Sell
18,219
-589
-3% -$51K 0.03% 154
2024
Q3
$1.69M Buy
18,808
+458
+2% +$38.5K 0.03% 138
2024
Q2
$1.44M Sell
18,350
-2,370
-11% -$194K 0.03% 150
2024
Q1
$1.81M Sell
20,720
-815
-4% -$69.6K 0.05% 135
2023
Q4
$1.77M Sell
21,535
-1,097
-5% -$83.6K 0.06% 123
2023
Q3
$1.77M Sell
22,632
-295
-1% -$24.7K 0.05% 105
2023
Q2
$2.02M Sell
22,927
-2,222
-9% -$191K 0.09% 98
2023
Q1
$2.03M Sell
25,149
-185
-0.7% -$15.1K 0.17% 92
2022
Q4
$1.97M Sell
25,334
-184
-0.7% -$14.9K 0.15% 89
2022
Q3
$2.06M Sell
25,518
-3,173
-11% -$285K 0.09% 78
2022
Q2
$2.58M Buy
28,691
+567
+2% +$57.5K 0.07% 70
2022
Q1
$3.12M Sell
28,124
-451
-2% -$47.6K 0.08% 63
2021
Q4
$2.96M Sell
28,575
-842
-3% -$97.5K 0.07% 77
2021
Q3
$3.69M Sell
29,417
-1,244
-4% -$161K 0.1% 48
2021
Q2
$3.81M Sell
30,661
-4,696
-13% -$590K 0.12% 49
2021
Q1
$4.18M Sell
35,357
-2,233
-6% -$262K 0.17% 50
2020
Q4
$4.4M Sell
37,590
-2,754
-7% -$303K 0.19% 48
2020
Q3
$4.19M Sell
40,344
-3,060
-7% -$307K 0.2% 54
2020
Q2
$3.98M Sell
43,404
-3,780
-8% -$362K 0.21% 51
2020
Q1
$4.25M Buy
47,184
+779
+2% +$82.9K 0.3% 42
2019
Q4
$5.26M Buy
46,405
+2,614
+6% +$287K 0.6% 36
2019
Q3
$4.76M Sell
43,791
-5,594
-11% -$584K 0.62% 33
2019
Q2
$4.81M Buy
49,385
+1,992
+4% +$182K 0.57% 41
2019
Q1
$4.32M Sell
47,393
-5,361
-10% -$480K 0.58% 45
2018
Q4
$4.8M Buy
52,754
+1,253
+2% +$117K 0.67% 36
2018
Q3
$5.07M Sell
51,501
-878
-2% -$81.2K 0.61% 40
2018
Q2
$4.48M Buy
52,379
+2,114
+4% +$177K 0.55% 46
2018
Q1
$4.03M Sell
50,265
-2,214
-4% -$183K 0.53% 48
2017
Q4
$4.24M Sell
52,479
-2,550
-5% -$204K 0.53% 46
2017
Q3
$4.28M Sell
55,029
-994
-2% -$82.5K 0.55% 49
2017
Q2
$4.97M Buy
56,023
+2,360
+4% +$199K 0.65% 36
2017
Q1
$4.32M Sell
53,663
-3,331
-6% -$260K 0.61% 38
2016
Q4
$4.06M Buy
56,994
+1,267
+2% +$99.5K 0.58% 41
2016
Q3
$4.82M Sell
55,727
-6,687
-11% -$583K 0.71% 29
2016
Q2
$5.42M Sell
62,414
-2,198
-3% -$178K 0.74% 30
2016
Q1
$4.85M Sell
64,612
-1,957
-3% -$147K 0.63% 37
2015
Q4
$5.12M Sell
66,569
-1,569
-2% -$118K 0.65% 36
2015
Q3
$4.56M Sell
68,138
-1,736
-2% -$128K 0.61% 37
2015
Q2
$5.18M Sell
69,874
-8,641
-11% -$660K 0.63% 36
2015
Q1
$6.12M Buy
78,515
+10,031
+15% +$760K 0.68% 31
2014
Q4
$4.95M Buy
68,484
+5,722
+9% +$397K 0.49% 51
2014
Q3
$3.89M Sell
62,762
-1,700
-3% -$108K 0.38% 72
2014
Q2
$4.11M Sell
64,462
-5,066
-7% -$308K 0.39% 70
2014
Q1
$4.28M Sell
69,528
-5,871
-8% -$342K 0.42% 66
2013
Q4
$4.33M Sell
75,399
-4,176
-5% -$237K 0.39% 78
2013
Q3
$4.24M Sell
79,575
-12,827
-14% -$690K 0.39% 77
2013
Q2
$4.76M Buy
+92,402
New +$4.57M 0.46% 58

Other funds holding MDT

Sumitomo Life Insurance's MDT Position: Q1 2026 in Review

Sumitomo Life Insurance increased its Medtronic (MDT) stake by 2.2% in Q1 2026, buying an estimated $18.8K and bringing the position to 8,972 shares worth $777K. The position accounts for 0.02% of the portfolio, ranked #217.

Sumitomo Life Insurance first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.12M in Q1 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sumitomo Life Insurance held 8,972 shares of Medtronic worth $777K as of Q1 2026.
  • Sumitomo Life Insurance bought 196 Medtronic shares in Q1 2026, an estimated $18.8K.
  • Medtronic made up 0.02% of Sumitomo Life Insurance's portfolio in Q1 2026, its #217 holding.
  • Sumitomo Life Insurance first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Sumitomo Life Insurance's Medtronic position peaked at $6.12M in Q1 2015.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.